Protective Effects of MK‐801 on Apoptosis in Immature Rats With Traumatic Brain Injury
International Journal of Developmental Neuroscience · 2025
DOI: 10.1002/jdn.70043 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, 2025. Verfasst von Ayşe Çiğel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Izmir Democracy University Faculty of Medicine, Izmir, Turkey. Hauptthemen laut MEDLINE: Dizocilpine Maleate, Apoptosis, Brain Injuries, Traumatic, Neuroprotective Agents. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Traumatic brain injury (TBI) is a major public health problem and an essential cause of morbidity and mortality during childhood. The aim of this study was to evaluate the apoptotic effects of MK‐801, a noncompetitive NMDA receptor antagonist, on hippocampal damage in 10‐day‐old rat pups exposed to contusion injury.
Methods
Forty‐two Wistar Albino rats were randomly assigned to three groups ( n = 14 per group): control, trauma and MK‐801 treatment. In the treatment group, MK‐801 was administered intraperitoneally at a dose of 1 mg/kg immediately after induction of TBI. Apoptotic damage in the hippocampal dentate gyrus (DG) and CA1 regions was assessed using immunoreactivity for BAX, cytochrome c and caspase‐3.
Results
The control group showed low levels of BAX and cytochrome c immunoreactivity in the hippocampus, whereas the TBI group exhibited markedly increased reactions. Cytochrome c immunoreactivity appeared in a granular pattern within neurons of the DG region. In the MK‐801 treatment group, both BAX and cytochrome c immunoreactivities were reduced compared to the TBI group. While only weak caspase‐3 immunoreactivity was observed in the control group, intense immunoreactivity was detected in both the DG and CA1 regions of the hippocampus in the TBI group. In contrast, caspase‐3 immunoreactivity was notably reduced in the MK‐801 group compared to the TBI group.
Conclusion
This study demonstrated that treatment with MK‐801 significantly reduces apoptosis in the hippocampus by downregulating key pro‐apoptotic markers, including BAX, cytochrome c and caspase‐3. These findings suggest that MK‐801 exerts a neuroprotective effect by interfering with the intrinsic apoptotic pathway following TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Izmir Democracy University Faculty of Medicine, Izmir, Turkey.
- Department of Biochemistry, Dokuz Eylül University Vocational School of Health Services, Izmir, Turkey.
- Department of Histology and Embryology, Manisa Celal Bayar University Vocational School of Health Services, Manisa, Turkey.
- Department of Physiology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.
ORCID-Profile: Ayşe Çiğel, Oya Sayın, Seren Gülşen Gürgen, Talha Başar Koç, Ataç Sönmez
Zitieren
APA
Çiğel, A., Sayın, O., Gürgen, S. G., Koç, T. B., & Sönmez, A. (2025). Protective Effects of MK‐801 on Apoptosis in Immature Rats With Traumatic Brain Injury. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.70043
Vancouver
Çiğel A, Sayın O, Gürgen SG, Koç TB, Sönmez A. Protective Effects of MK‐801 on Apoptosis in Immature Rats With Traumatic Brain Injury. International Journal of Developmental Neuroscience. 2025. doi:10.1002/jdn.70043
BibTeX
@article{iel2025,
author = {Çiğel, Ayşe and Sayın, Oya and Gürgen, Seren Gülşen and Koç, Talha Başar and Sönmez, Ataç},
title = {Protective Effects of MK‐801 on Apoptosis in Immature Rats With Traumatic Brain Injury},
journal = {International Journal of Developmental Neuroscience},
year = {2025},
doi = {10.1002/jdn.70043}
}
EUVIMED